CHICAGO, Feb. 15, 2018 -- Allscripts (NASDAQ:MDRX) has signed a definitive agreement to sell its OneContent business to Hyland Software, Inc., a leading provider of content services solutions to the healthcare industry and beyond. The deal is expected to close in the second quarter once customary closing conditions are satisfied.
Allscripts acquired the OneContent business in late 2017 through the acquisition of McKesson’s EIS portfolio. Upon transaction close, the OneContent client base and associates will transition to Hyland. The two companies will operate independently until the deal closes.
Hyland’s content and image management solutions address the clinical, financial and operational needs of healthcare organizations around the world. We expect that Hyland will continue to support OneContent customers’ current solutions while enhancing the platform with new features and functionality, and refining the integration with Allscripts’ EHR systems.
“Hyland has world-class content and image management solutions, and OneContent is a great fit within their portfolio,” Allscripts President Rick Poulton said. “This deal is a triple win for Allscripts clients and shareholders as it allows us to efficiently recirculate capital; allows us to focus on our core businesses and allows us to maintain our strong, exciting partnership with Hyland.”
Houlihan Lokey acted as the exclusive financial advisor to Allscripts in connection with the sale of OneContent.
About Allscripts
Allscripts (NASDAQ:MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.
© 2018 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.
Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.
For more information contact:
Investors:
Dennis Olis
312-386-6700
[email protected]
Media:
Concetta Rasiarmos
312-447-2466
[email protected]


DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Macquarie Group Shares Jump as Third-Quarter Trading Conditions Improve Across Key Units
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Canadian Airlines Suspend Cuba Flights Amid Jet Fuel Shortage and U.S. Sanctions
Alphabet Plans Rare 100-Year Sterling Bond to Fund AI Expansion 



